Country Club Trust Company Has Decreased Teva Pharmaceutical Inds LTD (TEVA) Position; Last Week Howden Joinery Group Plc (LON:HWDN) Coverage

February 20, 2018 - By Ellis Scott

Country Club Trust Company decreased Teva Pharmaceutical Inds Ltd (TEVA) stake by 70.05% reported in 2017Q3 SEC filing. Country Club Trust Company sold 114,167 shares as Teva Pharmaceutical Inds Ltd (TEVA)’s stock declined 15.11%. The Country Club Trust Company holds 48,820 shares with $859,000 value, down from 162,987 last quarter. Teva Pharmaceutical Inds Ltd now has $21.25 billion valuation. The stock increased 0.43% or $0.09 during the last trading session, reaching $20.9. About 14.77 million shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since February 20, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.

Among 17 analysts covering Howden Joinery (LON:HWDN), 8 have Buy rating, 0 Sell and 9 Hold. Therefore 47% are positive. Howden Joinery had 112 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Monday, June 26 with “Hold”. Liberum Capital maintained Howden Joinery Group Plc (LON:HWDN) on Tuesday, July 11 with “Buy” rating. Jefferies maintained Howden Joinery Group Plc (LON:HWDN) rating on Monday, December 5. Jefferies has “Hold” rating and GBX 400 target. On Wednesday, September 9 the stock rating was maintained by Goldman Sachs with “Neutral”. The firm earned “Neutral” rating on Friday, April 28 by JP Morgan. Barclays Capital initiated the shares of HWDN in report on Monday, November 27 with “Equal-Weight” rating. The rating was maintained by Liberum Capital on Friday, March 10 with “Buy”. Goldman Sachs upgraded Howden Joinery Group Plc (LON:HWDN) rating on Monday, April 25. Goldman Sachs has “Neutral” rating and GBX 515 target. The stock has “Buy” rating by Liberum Capital on Wednesday, August 30. The firm earned “Buy” rating on Wednesday, April 13 by Goodbody. See Howden Joinery Group Plc (LON:HWDN) latest ratings:

20/02/2018 Broker: Berenberg Rating: Hold Old Target: GBX 450.00 New Target: GBX 450.00 Maintain
23/01/2018 Broker: Peel Hunt Rating: Hold Old Target: GBX 470.00 New Target: GBX 470.00 Maintain
16/01/2018 Broker: Liberum Capital Rating: Buy Old Target: GBX 506.00 New Target: GBX 540.00 Maintain
06/12/2017 Broker: Peel Hunt Rating: Hold Old Target: GBX 445.00 New Target: GBX 470.00 Maintain
27/11/2017 Broker: Barclays Capital Rating: Equal-Weight New Target: GBX 447.00 Initiate
07/11/2017 Broker: JP Morgan Rating: Neutral Old Target: GBX 440.00 New Target: GBX 460.00 Maintain
02/11/2017 Broker: Canaccord Genuity Rating: Speculative Buy Old Target: GBX 120.00 New Target: GBX 120.00 Maintain
02/11/2017 Broker: N+1 Singer Rating: Hold Maintain
02/11/2017 Broker: Shore Capital Rating: Buy Maintain
02/11/2017 Broker: Peel Hunt Rating: Hold Old Target: GBX 445.00 New Target: GBX 445.00 Maintain

Among 35 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 8 Sell and 18 Hold. Therefore 26% are positive. Teva Pharma had 146 analyst reports since July 21, 2015 according to SRatingsIntel. Piper Jaffray maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Friday, October 6 with “Hold” rating. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) earned “Perform” rating by Oppenheimer on Thursday, August 3. Goldman Sachs upgraded Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Monday, November 23 to “Buy” rating. The rating was downgraded by JP Morgan on Friday, January 20 to “Neutral”. Jefferies downgraded the stock to “Hold” rating in Wednesday, November 16 report. Cowen & Co maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Thursday, February 8 with “Hold” rating. Argus Research downgraded the stock to “Hold” rating in Tuesday, February 28 report. Oppenheimer maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) rating on Tuesday, June 27. Oppenheimer has “Buy” rating and $4100 target. Barclays Capital maintained the stock with “Equal-Weight” rating in Wednesday, October 4 report. Citigroup downgraded the stock to “Neutral” rating in Wednesday, August 16 report.

Country Club Trust Company increased Ishares Tr (EFA) stake by 22,713 shares to 219,247 valued at $15.01M in 2017Q3. It also upped Philip Morris Intl Inc (NYSE:PM) stake by 3,179 shares and now owns 4,935 shares. Pfizer Inc (NYSE:PFE) was raised too.

The stock increased 1.63% or GBX 7.5 during the last trading session, reaching GBX 466.6. About 409,890 shares traded. Howden Joinery Group Plc (LON:HWDN) has 0.00% since February 20, 2017 and is . It has underperformed by 16.70% the S&P500.

Howden Joinery Group Plc engages in the manufacture, distribution, and sale of kitchens and joinery products in the United Kingdom, France, Belgium, the Netherlands, and Germany. The company has market cap of 2.90 billion GBP. It offers kitchen families, cabinets, accessories, handles, worktops, sinks, and taps; appliances, including ovens, hobs, extractors, refrigerators, dishwashers, laundries, fridge-freezers, and appliance manuals; internal, sliding wardrobe, external, fire, French, and garage doors; door frames, linings, and casings; intumescent and acoustic products; and breakfast bars. It has a 16.26 P/E ratio. The firm also provides joinery products, such as hardware, skirting and tair parts, plus the tools, fixings, and accessories, as well as moldings; wood, timber, tile laminate, and vinyl floorings; flooring accessories; and bathroom cabinets.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>